
    
      This is an open label, non randomized prospective case series evaluating 3M Cavilon Advanced
      Barrier Film for the treatment of severe incontinence associated dermatitis (IAD) in the
      presence or absence of continued fecal or fecal and urinary incontinence. The product will be
      applied twice a week for a maximum duration of 3 weeks. Subjects will be followed twice a
      week until healing, for a maximum of 3 weeks or earlier, if discharged from the facility.
      During the study period, the frequency and intensity of their incontinence will be monitored,
      twice a week photographic documentation and IAD site assessments will be completed.
    
  